Leo J. Redmond
Directeur/Membre du Conseil chez Presidio Pharmaceuticals, Inc.
Postes actifs de Leo J. Redmond
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Presidio Pharmaceuticals, Inc.
 Presidio Pharmaceuticals, Inc. BiotechnologyHealth Technology Presidio Pharmaceuticals, Inc. discovers and develops small-molecule antiviral therapeutics. Its products in pipeline include NS5A, PPI-668 and PPI-383 for treating hepatitis C virus infections. The company was founded by Omar K. Haffar, Antoun Nabhan and David V. Jobes in March 2006 and is headquartered in San Francisco, CA. | Directeur/Membre du Conseil | 01/01/2011 | - |
| Directeur Financier/CFO | 01/03/2013 | 31/07/2019 | |
| President | 01/03/2013 | 31/07/2019 | |
| Secrétaire Général | 01/03/2013 | 31/07/2019 |
Historique de carrière de Leo J. Redmond
Anciens postes connus de Leo J. Redmond
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ALLAKOS INC. | Comptroller/Controller/Auditor | 01/08/2019 | 01/02/2021 |
| Directeur Financier/CFO | 01/08/2019 | 01/02/2021 | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Directeur Financier/CFO | 01/12/2000 | 01/12/2007 |
| The Genentech Foundation | Directeur Financier/CFO | 01/07/2004 | 01/12/2007 |
| Secrétaire Général | 01/07/2004 | 01/12/2007 | |
| PHARCO PHARMACEUTICALS | Directeur Financier/CFO | - | - |
| President | - | - |
Formation de Leo J. Redmond
| University of Kansas | Undergraduate Degree |
| UCLA Anderson School of Management | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 7 |
| Égypte | 2 |
Opérationnelle
| Director of Finance/CFO | 5 |
| President | 2 |
| Corporate Secretary | 2 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 3 |
| Miscellaneous | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ALLAKOS INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Presidio Pharmaceuticals, Inc.
Presidio Pharmaceuticals, Inc. BiotechnologyHealth Technology Presidio Pharmaceuticals, Inc. discovers and develops small-molecule antiviral therapeutics. Its products in pipeline include NS5A, PPI-668 and PPI-383 for treating hepatitis C virus infections. The company was founded by Omar K. Haffar, Antoun Nabhan and David V. Jobes in March 2006 and is headquartered in San Francisco, CA. | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
| The Genentech Foundation | Miscellaneous |
Pharco Pharmaceuticals, Inc.
 Pharco Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Pharco Pharmaceuticals, Inc. develops, manufactures, markets, distributes, and exports pharmaceutical products. It offers generics and branded generic drugs under the name of Pharco. The company was founded by Hassan Abbas Helmy in 1983 and is headquartered in Alexandria, Egypt. | Health Technology |
- Bourse
- Insiders
- Leo J. Redmond
- Expérience
